AI system to improve ovarian ultrasound diagnosis
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests an AI system that helps doctors read ovarian ultrasound images more accurately. You might qualify if you had an ovarian mass seen on ultrasound, had it surgically removed, and have clear images and lab results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a growth (mass) on your ovary that was seen on an ultrasound and didn't go away on its own.
- You had surgery to remove the mass, and lab tests were done on the tissue.
- The lab tests confirmed the mass is from the ovary (not another organ).
- The lab results were clear and not uncertain.
- The ultrasound images of the mass were clear – not blurry, overly dark or bright, or blocked by gas.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a specific ultrasound-based scoring tool can tell the difference between harmless (non-cancer) and harmful (cancer) ovarian masses during pregnancy. If you have a cyst or mass that’s at least 5 cm, your scan details may be used to validate the tool.
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
This study focuses on improving diagnosis of ovarian cancer. If you have an abnormal mass seen on ultrasound near the ovaries, the researchers may evaluate how best to identify whether it could be ovarian cancer.
This study is testing an AI system that uses your ultrasound or MRI images and blood test results to help doctors better diagnose ovarian tumors before surgery. It may lead to more accurate treatment planning.
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
This study uses machine learning to analyze ultrasound images of adnexal masses (growths near the ovaries or fallopian tubes) to help predict whether they are benign or malignant. It aims to improve diagnosis and reduce unnecessary surgeries.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.